Search form

Hologic Signs Multi-year ThinPrep Pap Test and Imaging System Contract for the Scottish National Cervical Screening Programme

New contracts include usage of ThinPrep Pap Test and Imaging System in all NHS cytology laboratories in Scotland

Hologic, Inc. (Hologic or the Company), a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, today announced that it had entered into five-year managed service contracts for its ThinPrep Pap Test with eight Health Boards in Scotland. The terms of each contract include the use of Hologic’s ThinPrep Imaging System in the eight Health Boards with cytology laboratories as part of the country’s National Cervical Screening Programme. Through this agreement, Hologic will now have contracts for its ThinPrep Pap Test and Imaging System that cover all of Scotland’s current cervical screening needs.

Scotland’s National Cervical Screening Programme was introduced in 1988 in an effort to reduce the incidence of invasive cervical cancer nationwide. Today, cervical screening is offered to all eligible women aged 20-60 every three years.

Allan Wilson, Cytology Consortia Manager, and Dr. Tim Palmer, Consortia Clinical Lead, both welcomed the award of the contracts. “We are pleased to continue our partnership with Hologic and to be able to offer the ThinPrep Pap Test and Imaging System as part of our National Cervical Screening Programme. This continued and long relationship with Hologic began with the introduction of ThinPrep in 2003. The new contracts provide us with many benefits, the most notable being the ability to offer world-class diagnostic screening technology to women while providing a continuity of services and cost savings throughout the Screening Programme.“

“We are pleased that the Screening Programme has elected to continue to offer Hologic’s ThinPrep Pap Test in Scotland and introduce our ThinPrep Imaging System to all of its laboratories, ”said Wayne Taylor, Vice President and General Manager, Europe. “The ThinPrep Pap Test and Imaging System combine to create one of the most comprehensive cervical cancer screening tests available today. Our ability to offer this technology in Scotland has taken cervical health screening to the next level which we believe will be of benefit to all Scottish women." 

About the Hologic ThinPrep Pap Test and ThinPrep Imaging System: 

The Hologic ThinPrep Pap Test is one of the most widely used methods for cervical cancer screening in the world.

The ThinPrep process begins with the patient's cervical sample being taken by the physician using a cervical sampling device that, rather than being smeared on a microscope slide as in a conventional Pap smear, is rinsed in a vial filled with Hologic's proprietary PreservCyt solution. This enables most of the patient's cell sample to be preserved before the cells can be damaged by air drying. The ThinPrep specimen vial is then labeled and sent to a laboratory equipped with a ThinPrep processor for slide preparation.

At the laboratory, the ThinPrep specimen vial is inserted into a ThinPrep processor, a proprietary sample preparation device which automates the process of preparing cervical slides for staining and microscopic examination. In the case of manual screening, the cytotechnologist screens each Pap test slide with a microscope to first determine the adequacy of the slide and to then examine the entire slide to differentiate diseased or abnormal cells from normal cells.

With the ThinPrep Imaging System, the screening process has been automated to combine the power of computer imaging technology and human interpretive skills. Prior to human review, the ThinPrep Imaging System rapidly scans and locates areas of interest for review. By directing the cytotechnologist to areas of interest on a slide, the system may increase a cytology laboratory's screening productivity and diagnostic accuracy.

About Hologic, Inc.

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health. With a comprehensive suite of technologies and a robust research and development program, Hologic is committed to improving lives. The Company is headquartered in Massachusetts. For more information, visit

Hologic, PreservCyt, ThinPrep and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Forward-Looking Statement Disclaimer

This News Release may contain forward-looking information that involves risks and uncertainties, including statements about the use of the Hologic ThinPrep Pap Test and Imaging System. There can be no assurance the test or systems will achieve the benefits described herein and that such benefits will be replicated in any particular manner as the actual effect of the use of the tests and systems can only be determined on a case-by-case basis depending on the particular circumstances and installation in question. Hologic expressly disclaims any obligation or undertaking to release publicly any updates or revisions to the data or statements presented herein to reflect any change in the Company's expectations or any change in events, conditions or circumstances on which any such data or statements are based. Certain factors that could adversely affect the Company's business and prospects are described in Hologic filings with the Securities and Exchange Commission.